Blanket Purchase Agreement V797D30085-36C24820A0028

Award Date 5/1/20
Last Date to Order 4/30/22
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 (VISN 10) awarded a Blanket Purchase Agreement (BPA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $809,835 single-award BPA, which utilizes Biofire Diagnostics' General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests, will provide reagents to VA facilities in...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 2 to Biofire Diagnostics LLC, a biotech company specializing in infectious disease diagnostic testing. The BPA, valued at $2,442,440.05, is a single-award contract established against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract...
This Blanket Purchase Agreement (BPA) contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is for the provision of PCR lab testing kits to support the VA healthcare system, with a total ceiling value of $749,137.80 and a period of performance through September 30, 2024. The contract was...
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Biofire Diagnostics, LLC. The BPA calls for molecular pathogen detection testing services at a cost per test of $1 under the Master GSA Schedule Invitro Diagnostics, Reagents, Test. Specifically, Biofire Diagnostics will provide COVID-19 testing for Veterans in VISN 8 at its location in Emigration Canyon, Utah from June 1, 2020 through...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests to Biofire Diagnostics, LLC. The BPA has a potential value of $695,000 and aims to procure COVID-19 test kits through March 2021 in response to the Coronavirus pandemic. A call against the BPA was issued for $167,395.49 to deliver Biofire Torch Systems for molecular diagnostic...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company. The BPA, valued at up to $7,000,000, is issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. It allows for streamlined, as-needed procurement of Biofire's advanced...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite delivery contract to Biofire Diagnostics, LLC to provide Biofire Film Array reagents. Biofire Diagnostics, LLC was awarded three firm fixed price delivery orders totaling $1,243,817.20 to supply these reagents from October 2021 through September 2026 in Emigration Canyon, Utah. The reagents are used with Biofire's Film Array system, which can rapidly detect respiratory,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded an indefinite delivery contract vehicle to Biofire Diagnostics, LLC for the provision of Biofire reagents and associated products. Under the terms of the award vehicle, three firm fixed price delivery orders were issued for reagents OY, OY1, and an unspecified reagent. The delivery orders have potential values of $550,736.25, $550,736.25, and $549,856.05 respectively, and run from...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 19 awarded a Blanket Purchase Agreement (BPA) contract to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company specializing in syndromic infectious disease testing equipment and reagents. The $4.65 million BPA, with a period of performance through September 2026, provides a long-term vehicle for the VA to procure Biofire reagents and extended warranties for maintenance of Biofire diagnostic...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a blanket purchase agreement to Biofire Diagnostics LLC for molecular pathogen detection services. Biofire will provide products and services to support VHA programs such as COVID-19 testing, diagnostic testing, and infectious disease screening. Performance locations include Utah, Florida, and other states. Estimated values range from $30k to over $1.5M for individual task orders, with periods of performance from 6 months to 4 years.

As the prime contractor, Biofire will utilize its GSA Schedule for in vitro diagnostics, reagents, and tests to supply molecular diagnostic testing equipment, supplies, and expertise. This will assist VHA Network 8 in identifying pathogens impacting veterans' health across various medical centers and clinics. No set-aside designations were specified. The contract establishes long-term vehicles for the VA customer to procure infectious disease testing on an as-needed basis through task orders against the master agreement.

Generated 3/7/24, 9:16 AM